Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.

Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.

<h4>Background</h4>Little is known about the effects of intermittent preventive treatment of malaria in pregnancy (IPTp) on the health of sub-Saharan African infants. We have evaluated the safety of IPTp with mefloquine (MQ) compared to sulfadoxine-pyrimethamine (SP) for important infant...

Full description

Bibliographic Details
Main Authors: María Rupérez, Raquel González, Ghyslain Mombo-Ngoma, Abdunoor M Kabanywanyi, Esperança Sevene, Smaïla Ouédraogo, Mwaka A Kakolwa, Anifa Vala, Manfred Accrombessi, Valérie Briand, John J Aponte, Rella Manego Zoleko, Ayôla A Adegnika, Michel Cot, Peter G Kremsner, Achille Massougbodji, Salim Abdulla, Michael Ramharter, Eusébio Macete, Clara Menéndez
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-02-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1001964

Internet

https://doi.org/10.1371/journal.pmed.1001964

Similar Items